Zealand Pharma A/S at Jefferies Healthcare Conference Transcript
/-
Thank you very much, Lucy, and hello to everybody. And we are really pleased to be here today and present to you the Zealand story. I will ask you to at this point just give a quick introduction to the story for the ones that are new to the case. And otherwise, we are happy to answer any questions. I have also Anna Krassowska from Investor Relations with me today.
So just quickly a bit of background. We are a Danish biotech just located outside of Copenhagen. We actually have 25 years in the making. So we are celebrating our 25 years anniversary this year. We are about 220 people. Majority of these, outside -- just located outside of Copenhagen and 10 folks here in the US. We are listed in Nasdaq in Copenhagen, have a market cap here end of May of just above DKK15 billion, USD2.2 billion, and we currently have a cash position of approximately DKK2.5 billion or $350 million (sic - see slide 5 "$360 million"). So we have cash run rate until 2026. We are right now guiding for approximately DKK800 million, DKK900 million in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
